| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017726249 |
| P356 | DOI | 10.1186/S40478-015-0215-1 |
| P932 | PMC publication ID | 4473839 |
| P698 | PubMed publication ID | 26091809 |
| P5875 | ResearchGate publication ID | 279259511 |
| P2093 | author name string | Tomio Arai | |
| Shigeo Murayama | |||
| Yuko Saito | |||
| Hiroyuki Hatsuta | |||
| Masaki Takao | |||
| Kazutoshi Nishiyama | |||
| Yuta Nakano | |||
| Hiroyuki Sumikura | |||
| Akane Nogami | |||
| Akiko Uchino | |||
| P2860 | cites work | A harmonized classification system for FTLD-TDP pathology | Q24630756 |
| “Mini-mental state” | Q25938989 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q28131672 | ||
| TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis | Q29615597 | ||
| TDP-43 is a key player in the clinical features associated with Alzheimer's disease | Q34232167 | ||
| TDP-43 in aging and Alzheimer's disease - a review | Q34566756 | ||
| Pathological 43-kDa Transactivation Response DNA-Binding Protein in Older Adults With and Without Severe Mental Illness | Q34632269 | ||
| Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). | Q36727765 | ||
| Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies | Q36860214 | ||
| TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies | Q36951533 | ||
| TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease | Q37179756 | ||
| Stages of pTDP-43 pathology in amyotrophic lateral sclerosis | Q37202139 | ||
| Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. | Q37425165 | ||
| Staging TDP-43 pathology in Alzheimer's disease | Q37621617 | ||
| Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD). | Q37678074 | ||
| Neuropathological diagnostic criteria for Alzheimer's disease. | Q40475689 | ||
| Senile dementia with tangles (tangle predominant form of senile dementia). | Q41740116 | ||
| Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa. | Q46017333 | ||
| Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies | Q46396965 | ||
| Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases | Q48095281 | ||
| A new clinical scale for the staging of dementia. | Q52220854 | ||
| Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies. | Q53299106 | ||
| Lewy body-related alpha-synucleinopathy in aging | Q80410949 | ||
| Staging of argyrophilic grains: an age-associated tauopathy | Q80797442 | ||
| Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease | Q82754492 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 35 | |
| P577 | publication date | 2015-06-20 | |
| P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
| P1476 | title | Incidence and extent of TDP-43 accumulation in aging human brain | |
| P478 | volume | 3 |
| Q38841003 | "New Old Pathologies": AD, PART, and Cerebral Age-Related TDP-43 With Sclerosis (CARTS). |
| Q58566479 | Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage |
| Q36692073 | Altered Proteins in the Aging Brain |
| Q92261994 | Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS |
| Q91744531 | Amide proton transfer-weighted magnetic resonance imaging of human brain aging at 3 Tesla |
| Q91739737 | Associations of amygdala volume and shape with transactive response DNA-binding protein 43 (TDP-43) pathology in a community cohort of older adults |
| Q48388590 | Brain tau deposition linked to systemic causes of death in normal elderly |
| Q64866611 | Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype |
| Q90655355 | Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice |
| Q60043858 | Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies |
| Q48122054 | Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy |
| Q55027556 | Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study. |
| Q92267709 | LATE to the PART-y |
| Q64385732 | Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. |
| Q28854599 | Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death |
| Q38866202 | Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies |
| Q36706031 | Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies |
| Q37230835 | Neuropathology of supercentenarians - four autopsy case studies |
| Q38915426 | Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi |
| Q58090414 | Phosphorylated TDP-43 Staging of Primary Age-Related Tauopathy |
| Q47727180 | Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration. |
| Q38644831 | Prevalence of TDP-43 proteinopathy in cognitively normal older adults: systematic review and meta-analysis. |
| Q90059432 | Primary age-related tauopathy in a Chinese cohort |
| Q92591355 | Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort |
| Q93210804 | TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study |
| Q89476365 | TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease |
| Q38382398 | TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD. |
| Q48586134 | TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing |
| Q53397720 | TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease. |
| Q88373808 | TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions |
| Q64105715 | Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage |
| Q46251905 | The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases |
| Q90100699 | The mutational landscape of a prion-like domain |
| Q48949710 | Updated TDP-43 in Alzheimer's disease staging scheme |
Search more.